DiFusion Technologies and German-based specialty chemicals company Evonik Degussa have collaborated to develop a PEEK based product, CleanFUZE, a new medical polymer that prevents infection and promotes bone and tissue integration. ...
Tags: PEEK, CleanFUZE, medical polymer
Janssen Biotech and Janssen Biologics have submitted a supplemental biologics license application (sBLA) to the US Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMA) seeking approval of Simponi ...
Tags: Simponi, golimumab, active ulcerative colitis, anti-tumor necrosis factor
Athera Biotechnologies has released the results of a study which linked the low levels of plasma anti-PC, measured with Athera's CVDefine kit, to a high risk of vein graft failure after bypass surgery. The report is based on the data ...
Ethicon has introduced a new portfolio of knotless tissue control devices to provide multiple clinical advantages for surgeons in wound closing. The STRATAFIX devices, which have more points of fixation than traditional sutures, ...
Tags: wound closing technology, knotless tissue control devices
Accuray has received 510(k) clearance for its new CyberKnife M6 Series from the US Food and Drug Administration (FDA). Designed for use in stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments, the ...
Tags: FDA, stereotactic radiosurgery, stereotactic body radiation therapy
The US Food and Drug Administration (FDA) has cleared Halt Medical's minimally invasive technology, designed for treating uterine fibroids. The Acessa technology, which is designed for preserving the normal function of the uterus, ...
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
Abbott has signed an agreement to acquire all global rights to develop and commercialize AP214 from Action Pharma. AP214 is a hormone analogue which is being developed to prevent acute kidney injury associated with major cardiac surgery ...
Tags: AP214, Abbott, Action Pharma
HealthTrust, a group purchasing organization, has awarded a contract to EndoChoice to provide endoscope care, cleaning and protection accessories. Under the deal, EndoChoice will provide its EndoKit, CinchPad, SafeStart bedside clean kit, ...
Tags: HealthTrust, EndoChoice, endoscope care, reprocessing endoscopes
AMSilk announced that the silicone breast implants with its spider silk-based coating have reduced immune system-based side-effects in the preclinical studies. The BioShield-S1 coating,which is comprised of a thin layer of recombinant ...
Tags: AMSilk, side-effects, silicone breast implants, immune system
Janssen Research & Development has submitted a supplemental new drug application (sNDA) with FDA, seeking approval to use Xarelto (rivaroxaban), an oral anticoagulant, to reduce the risk of stent thrombosis in patients with acute coronary ...
St Jude Medical has implanted the first patient with its Portico Transcatheter aortic heart valve designed to treat patients with severe aortic stenosis who are at high risk of needing open-heart surgery, using the Transapical delivery ...
Tags: portico transcatheter aortic heart valve, St Jude Medical
Pacira Pharmaceuticals, a specialty pharmaceutical company, has launched EXPAREL (bupivacaine liposome injectable suspension) in the US. EXPAREL is indicated for administration into the surgical site to produce postsurgical analgesia. ...
Tags: pacira pharmaceuticals, EXPAREL
Taipei, Nov. 9, 2012 (CENS)--Taiwan`s medical-device production value in 2012 is expected to continue to grow 7%, and the government targets five fields to focus in the local medical-device industry, according to Woody Duh, Vice Minister, ...
Mobius Therapeutics, an ophthalmic company, has begun commercial shipments of Mitosol (mitomycin for solution) kit for ophthalmic use. Mitosol will provide a new system for delivering a precise dose of its active ingredient, mitomycin-c, ...